医学伦理研究助手
前沿
论文精读

论文

用于mRNA连续纯化的过程分析技术(PAT):沉淀与切向流过滤

Biotechnol Bioeng · 2026年9月23日 · Bhawnani 等 9 位作者

问这篇
一分钟了解要点开发相位分辨PAT框架,实现mRNA沉淀纯化过程的实时监控。

不需要生物学背景,多打比方

正在获取全文并生成讲解(拿不到全文就依据摘要)…

已等待 0 秒大约需要 10–20 秒

可以先看别的,做好了会自动出现在这里。

这篇还没有动画

动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。

目前只拿到了摘要全文暂时拿不到(可能不是免费全文)。下面是论文摘要。

摘要Abstract

摘要第 1 段问这一段

Continuous downstream processing of messenger ribonucleic acid (mRNA) therapeutics requires purification strategies that are scalable, robust, and capable of removing product- and process-related impurities from in vitro transcription mixtures. Precipitation-based purification coupled with tangential flow filtration (TFF) has recently been demonstrated as a chromatography-free route for continuous mRNA purification. However, implementation of this approach requires real-time monitoring strategies that can distinguish the product-rich precipitated phase from the impurity-rich liquid phase, as well as phase-dependent transport behavior across the integrated process. In this work, we develop a phase-resolved process analytical technology (PAT) and residence time distribution (RTD) framework for continuous mRNA purification by PEG/NaCl precipitation and sequential TFF. Inline UV-Vis spectroscopy and LED-based optical density measurements were used concurrently to separate nucleic-acid absorbance from turbidity-driven responses associated with suspended mRNA precipitates. RTD experiments with dissolved and precipitated tracers revealed phase-dependent transport behavior in both the tubular precipitator and TFF module, which was quantified using axial dispersion and tanks-in-series models. During integrated operation, inline PAT captured startup, steady-state, and washout behavior, while stable TMP indicated operation without observable membrane fouling. This work demonstrates that precipitation-based continuous mRNA purification can be strengthened through phase-resolved monitoring and RTD-based process understanding, providing a framework for robust development of continuous downstream processes for nucleic acid therapeutics.

这篇对您:
讲解或动画有问题: